Page last updated: 2024-11-05
4-methyl-3-heptanone
Description
4-methyl-3-heptanone: the principal alarm phermone of Atta texana & Atta cephalotes [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
4-methylheptan-3-one : A dialkyl ketone that is 4-methylheptane substituted by an oxo group at position 3. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
Cross-References
ID Source | ID |
PubMed CID | 22512 |
CHEBI ID | 195232 |
SCHEMBL ID | 268557 |
MeSH ID | M0052322 |
Synonyms (18)
Synonym |
3-heptanone, 4-methyl- |
4-methyl-3-heptanone |
6137-11-7 |
4-methylheptan-3-one |
ethyl 1-methylbutyl ketone |
fema 4966 |
CHEBI:195232 |
LMFA12000031 |
AKOS012857284 |
SCHEMBL268557 |
MVLRILUUXLBENA-UHFFFAOYSA-N |
mfcd00039949 |
A4JK9GW89J |
4-methylheptan-3-one, (+/-)- |
fema no. 4966 |
DTXSID20884228 |
EN300-99015 |
Z1138187109 |
Roles (3)
Role | Description |
flavouring agent | A food additive that is used to added improve the taste or odour of a food. |
alarm pheromone | A pheromone which is released by an organism when damaged by a predator which warns other individuals that there is a danger. |
mammalian metabolite | Any animal metabolite produced during a metabolic reaction in mammals. |
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Drug Classes (1)
Class | Description |
dialkyl ketone | |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (8)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (50.00) | 29.6817 |
2010's | 2 (25.00) | 24.3611 |
2020's | 2 (25.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 28.01
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 28.01 (24.57) | Research Supply Index | 2.30 (2.92) | Research Growth Index | 4.52 (4.65) | Search Engine Demand Index | 31.58 (26.88) | Search Engine Supply Index | 2.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 9 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |